1. Introduction {#sec0005}
===============

Schistosomiasis is a chronic and debilitating disease that affects 600 million people in developing countries of whom 85% are located in sub-Saharan Africa and an estimated 250 million worldwide require treatment ([@bib0045]). An estimated 20 million infected persons currently suffer from a severe form of the disease ([@bib0045]) resulting in more than 300,000 related deaths annually ([@bib0135]; [@bib0265]; [@bib0320]).

Four major forms of human schistosomiasis (*S. mansoni*, *S. haematobium*, *S. intercalatum* and *S. guineensis*) are recognised in sub-Saharan Africa. The different clinical manifestations are related to the species-specific egg-laying sites: the mesenteric venous systems for intestinal *Schistosoma mansoni*, *S. intercalatum* and *S. guineensis*, as well as the vesical veins of the urogenital system for *S. haematobium* ([@bib0015]; [@bib0335]) and *Schistosoma* spp. hybrids (e.g. *S. haematobium*/*S. curassoni* and *S. haematobium*/*S. bovis* hybrids) ([@bib0140]; [@bib0170]).

*Schistosoma* spp. eggs cause most of the pathology ranging from anaemia, haematuria, bloody diarrhoea and abdominal pain, to organ-specific effects such as chronic hepatosplenism, periportal fibrosis, and ureteral and/or bladder fibrosis, calcification of urinary tract and bladder cancer ([@bib0050]). The mainstay of the current control strategy against schistosomiasis in endemic regions consists of preventive chemotherapy (PCT) with mass drug administration (MDA) with praziquantel (PZQ), to reduce infection and associated morbidity through regular treatment ([@bib0370]). Longitudinal cohort follow-up morbidity data are essential for long term impact monitoring and evaluation of PCT strategy. However, control programmes typically collect prevalence and intensity of infection data and rarely morbidity data, due to its high cost.

In Mali, both urogenital and intestinal forms of schistosomiasis remain endemic throughout the country with geographically varying degrees of prevalence ([@bib0040]; [@bib0060]) yet clinical and population-based data are scarce because reports focus on prevalence and infection intensity rather than associated morbidities (Personal communication with Moussa Sacko, National Schistosomiasis Control Program, Mali). Since the start of the 2004 schistosomiasis control program in Mali, baseline and follow-up surveys showed that some areas are reducing well, others have ongoing very high infection prevalence and intensities for both *S. mansoni* and *S. haematobium* infections. One of the highest ongoing endemicity areas is that of the Office du Niger (ON), Ségou region, despite control with regular, annual PCT ([@bib0165]). School age children in this area are almost universally infected with *Schistosoma* spp**.** The Office du Niger is a rice-irrigation area which harbors two main *Schistosoma* species, *S. haematobium* and *S. mansoni*. A control effort with PZQ drug and mollusciciding programs in Mali commenced in the early 1970s, then again between 1982 and 1992, focusing on the ON and the Plateau Dogon region with funds from the German Technical Co-operation (GTZ) ([@bib0025]; [@bib0305]). A new initiative of national schistosomiasis control program of MDA commenced in 2004 under the Schistosomiasis Control Initiative (SCI) ([@bib0035]; SCI) that targeted school children with a single dose (40 mg/kg) of PZQ. Since 2007, MDA with PZQ has been steadily scaled up achieving 100% geographical coverage and 72--100% programme coverage as part of the integrated national control programme on NTDs, funded by the United States Agency for International Development (USAID) ([@bib0075]). Throughout the ongoing control program morbidity data (anaemia, haematuria, bladder pathology, liver and spleen morbidity) have not been routinely collected due to lack of resources. The aim of our study was to assess schistosome-induced morbidity in *S. haematobium* and *S. mansoni* infections with a particular hypothesis that the estimation of schistosome infections-related morbidity at micro-geographical level might be an indicator of the degree of the pathologies in an endemic irrigated region. Here we reported the morbidity associated with schistosomiasis that include anaemia, bladder pathology and haematuria, as a micro-epidemiological evaluation of the initial success of the PZQ chemotherapy program in the region.

2. Materials and methods {#sec0010}
========================

2.1. Study area, population and design {#sec0015}
--------------------------------------

At the start of the SCI MDA program for Mali, a random selection of 194 school-age children aged 6--14 years were surveyed from Kokry-Bozo village in the Office du Niger rice irrigation scheme of Mali. The cross-sectional study was completed during the 2005 SCI survey (described in full ([@bib0150])). Previous parasitological and morbidity baseline surveys in the ON occurred during March and April of 2004 while the follow-up survey was performed one year later in May 2005. Since 2004, Ségou and Macina districts (located in Ségou region) received regular yearly rounds of MDA till 2018 except in 2007. At the time of our study, school children in this area had received two MDA treatments with PZQ: (a) one after baseline data collection in March-April 2004 and (b) another during preventive chemotherapy intervention in February 2005. Kokry-Bozo baseline morbidity data on anaemia, haematuria and abnormal bladder/liver/spleen pathologies were only collected for the February 2005 survey. We report findings from the MDA control programme that have not been previously published by ([@bib0150]). The Office du Niger is known *a priori* to be highly endemic for schistosomiasis and malaria ([@bib0035]; [@bib0260]; [@bib0280]). Children provided fresh urine, stool and finger-prick blood samples and had ultrasonographic assessment for bladder abnormality.

2.2. Parasitological examinations {#sec0020}
---------------------------------

Stool and urine samples were collected from children between 09:00 and 13:00 h. Duplicate urine syringe filtration slides ([@bib0215]) were used to determine *S. haematobium* prevalence and intensity. Duplicate Kato-Katz (K-K) thick smear slides ([@bib0120]) were used to define the prevalence and intensity of *S. mansoni* infection. Duplicate testing on the same stool or urine sample was performed once for each child due to logistical constraints although replicate stool samples over several days improves the accuracy of estimates of the intensity of schistosomiasis ([@bib0070]; [@bib0295]). The mean number of eggs per 10 ml of urine for *S. haematobium* and the mean number of eggs per gram (EPG) of stool for *S. mansoni* were used to define intensity of infections as to low, moderate or high intensity in accordance with World Health Organization established intensity cut-off values ([@bib0360]). All laboratory tests were performed by the same experienced laboratory technicians from the Malian National Public Health Research Institute.

2.3. Determination of haemoglobin concentrations {#sec0025}
------------------------------------------------

Haemoglobin (Hb) was estimated from 100*μ*l of finger prick blood using a portable battery-operated HemoCue® photometer (HemoCue, Angelholm, Sweden) ([@bib0345]). The same experienced clinical nurses performed all blood collection who were blinded to parasitological results. Anaemia was defined for age and sex in accordance with the WHO guidelines ([@bib0355]). Anaemia was defined as an Hb\<11.5 g/dl for children aged 6--11 years, Hb\<12.0 g/dl for children aged 12--13 years, Hb\<13.0 g/dl for males Hb\>13 years and Hb\<12.0 g/dl for girls Hb\>13 years ([@bib0365]). Severity of anaemia was classified ([@bib0365]) as: severe Hb\<7.0 g/dl, moderate Hb 7.0--9.9 g/dl, mild Hb10--11.9 for girls and boys ≤12 years, and boys \>13 years as Hb 10--12.99 g/dl ([Table 1](#tbl0005){ref-type="table"}).Table 1Prevalence of anaemia among 189 children by age and sex.Table 1DemographicsAnaemia status % \[95%%CI\] (N)OR \[95% CI\]P (χ2)SevereModerateMildNormal*Sex*Male (n = 88)8 \[3-15\] (7)55 \[44-65\] (48)34 \[25-44\] (30)3 \[1-9\] (3)4.5 \[1.3-20.3\]0.01 (6.28)Female (n = 101)5 \[2-11\] (5)40 \[30-49\] (40)42 \[33-51\] (42)14 \[8-22\] (14)1*Age*6-9 years (n = 67)7 \[3-16\] (5)37\[26-49\] (25)40 \[29-52\] (27)15 \[8-25\] (10)110-14 years (n = 122)6 \[5-11\] (7)52 \[43-61\] (63)37 \[29-46\] (45)6 \[2-11\] (7)2.9 \[1.04-8.4\]0.03 (4.46)**Total (N = 189)6 \[3-10\] (12)47 \[39-54\] (88)38 \[31-5\] (72)9 \[5-14\] (17)**[^1]

2.4. Urine examination for micro-haematuria {#sec0030}
-------------------------------------------

Urine reagent strips (Hemastix®; Bayer, Tarrytown, NY) were used to detect blood in urine specimens ([@bib0095]). The level of micro-haematuria (invisible haematuria) was graded semi-quantitatively as negative, trace haemolysed or trace non-haemolysed. Non-haemolysed was graded in accordance with the manufacturer recommendations as: + (˜25 erythrocytes/*μ*l); ++ (˜80 erythrocytes/*μ*l); +++ (˜200 erythrocytes/*μ*l).

2.5. Ultrasound examination {#sec0035}
---------------------------

A portable ultrasonography device (SSD-500®; Aloka, Tokyo, Japan) equipped with a convex 3.5-Mhz transducer (probe) was used for bladder examination (described in detail ([@bib0105]; [@bib0150]; [@bib0245]) in children with abnormal pathology and performed by the same physician trained in the Niamey WHO protocol ([@bib0235], [@bib0240]; [@bib0350]).

2.6. Statistical analyses {#sec0040}
-------------------------

Data management and statistical analysis were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA) and Stata v.11.0 ([@bib0275]) with chi-square (χ2) test for linear trend performed by Stata v.11.0 ([@bib0275]). Pearson's chi-square test was used to test significance in differences between normal Hb level compared with three levels of anaemia and bladder pathology and haematuria by age and sex. The percentage of children displaying anaemia, bladder pathology and haematuria were determined by infection status: single species infections, co-infected or uninfected.

Multivariate logistic regression models were fitted using Stata v.11.0 ([@bib0275]) to enable the associations between several covariates on the pathological manifestations to be tested simultaneously. Odds Ratios (OR), 95% Confidence Intervals (95%CI), *P*-values and z test were established from multivariate logistic regression analysis for urogenital-related morbidities, haematuria and anaemia pathologies. Separate models were developed for each of the morbidity outcomes of abnormal bladder pathology, micro-haematuria and anaemia structured as binary variables. Potential predictors included in the model were infection intensity (classified on infection intensities category using WHO standards), age and sex. The assumption of linear effects of infection intensity classes were tested using Akaike's Information Criterion (AIC) ([@bib0330]) to compare models fitted for separate effects for each combination of *S. mansoni* and *S. haematobium* intensity classes. The AIC comparisons identified from the models fitting sex, age group and infection intensity classes) yielded better fit. When linear effects were incorporated, the intensity classes for *S. haematobium* infection were assigned 0 for 'not infected' (0 egg/10 ml), 1 for 'light' (1--49 eggs/10 ml) and 2 for 'heavy' (≥ 50 eggs/10 ml). Intensity classes for *S. mansoni* infection were assigned 0 for 'not infected' (0 epg), 1 for 'light' (1--99 epg), 2 for 'medium' (100--399 epg) and 3 for 'heavy' (≥ 400 epg). Children were categorised into two age groups: younger age 6--9 years and older age 10--14 years. *P*-values of ≤0.05, using a two-sided test, were considered statistically significant. The sample size does not provide precision to less than one decimal places therefore odd ratios were rounded up to one decimal place for all odds \>0.99. Proportions were also rounded up.

2.7. Ethical considerations {#sec0045}
---------------------------

Ethics approval was obtained from the Mali Ministry of Health, London Research Ethics Committee of the Imperial College (EC NO: 03.36. R&D No: 03/SB/033E) and the University of New South Wales (UNSW Sydney). Prior to the recruitment of the children, verbal informed consent was first obtained from the parents/guardians and then each child was asked for his/her verbal consent as participation was voluntary. Consent was recorded with the village committee that comprised of parents, teacher\'s director, teachers and community leader. All children found to be diagnosed with schistosomiasis were treated in accordance with the WHO recommended dose of PZQ (40 mg/kg).

3. Results {#sec0050}
==========

A total of 194 schoolchildren aged 6--14 years were enrolled. The mean age was 10.5 years and the ratio of girls to boys was 1.1:1. Nearly all (97%; 189/194) participants tested positive for at least one schistosome species; 80% (155/194) co-infection with *S. haematobium/S. mansoni* and 17% (33/194) single parasitic infection (13% *S. mansoni*; 4% *S. haematobium*). The prevalence of *S. mansoni* by intensity was 42% (81/194) heavy, 24% (47/194) moderate and 27% (53/194) light. The prevalence of *S. haematobium* by intensity was 26% (50/194) for heavy and 59% (114/194) for light.

3.1. Prevalence of pathological manifestations {#sec0055}
----------------------------------------------

### 3.1.1. Anaemia {#sec0060}

Anaemia was diagnosed in 91% (172/188) of children infected regardless of schistosome species ([Table 1](#tbl0005){ref-type="table"}). The mean Hb level for all children was 10.5 g/dl (95%CI 9.8--11.2 g/dl). The prevalence of severe, moderate and mild anaemia was 6%, 47% and 38% respectively. Although the prevalence of anaemia was high in both males and females infected (96% and 86% respectively) and was 4.5 times more likely to be diagnosed in males than females (OR 4.5, 95%CI 1.3--20.3, *P = 0.01*) ([Table 1](#tbl0005){ref-type="table"}). The prevalence of anaemia was high in all infected children and anaemia was 2.9 times more likely to be diagnosed in older children than younger children (OR 2.9, 95%CI 1.04--8.0, *P = 0.03*).

### 3.1.2. Bladder pathology and micro-haematuria {#sec0065}

Bladder pathology was present in 18% of children and did not significantly differ by sex (OR 1.01, 95%CI 0.5--2.1, *P = 0.87*) or age (OR 0.84, 95%CI 0.37--1.8, *P* = 0.67) ([Table 2](#tbl0010){ref-type="table"}). Micro-haematuria was present in 60% of children and did not significantly differ by sex (OR = 1.3, 95%CI 0.73--2.3, *P = 0.36*) or age (OR 0.71, 95%CI 0.38--1.3, *P = 0.27*).Table 2Frequency of bladder pathology and micro-haematuria among 194 children.Table 2DemographicsBladder pathologyMicro-haematuria%\[95%CI\] (N)OR \[95%CI\]P (χ2)% \[95%CI\] (N)OR \[95%CI\]P (χ2)**Sex**Male (n = 93)19 \[11-27\] (17)159 \[47-67\] (53)1Female (n = 101)18 \[11-26\] (18)1.01 \[0.5-2.1\]0.87 (0.03)63 \[54-72\] (64)1.3 \[0.73-2.3\]0.36 (0.82)**Age**6-9 years (n = 67)16 \[9-27\] (11)166 \[54-76\] (44)110-14years (n = 127)19 \[13-26\] (24)0.84 \[0.37-1.8\]0.67 (0.18)59 \[49-66\] (73)0.71 \[0.38-1.3\]0.27 (1.23)**Total18 \[13-24\] (35)60 \[53-67\] (117)**

### 3.1.3. Bladder pathology, haematuria and anaemia by infection {#sec0070}

The prevalence of bladder pathology in children with a co-infection of *S. haematobium* and *S. mansoni* was 19% (95%CI 14%--26%, 29/156) (not shown in Tables). More than half (61%, 95%CI 54%--68%, 116/189) the infected children had haematuria with anaemia present in almost all infected children: *S. haematobium* only (87%, 95%CI 18%--92%, 7/8), *S. mansoni* only (95%, 95%CI 71%--97%, 24/25), co-infected (90%, 95%CI 59%--74%, 140/156).

3.2. Logistic regression analyses for the association between the intensity of schistosomiasis infection status, gender, age and pathological manifestations {#sec0075}
------------------------------------------------------------------------------------------------------------------------------------------------------------

As infection intensity of *S. haematobium* increased bladder pathology (OR 2.4, 95%CI 1.3-4.5*, P*\< 0.01) and haematuria (OR 6.7, 95%CI 3.3-13.6*, P*\< 0.001) were significantly more common ([Table 3](#tbl0015){ref-type="table"}). As infection intensity increased with *S. mansoni* anaemia (OR 2.0, 95% CI 1.1-3.9*, P*\< 0.05) was significantly more common.Table 3Linear covariate analysis for risk factors associated with pathology in 194 children.Table 3Bladder pathologyHaematuriaAnaemiaOR (95%CI)P (z)OR (95%CI)P (z)OR (95%CI)P (z)Male111Female0.96 (0.44-2.1)0.92 (-0.10)1.43 (0.73- 2.8)0.99 (1.06)0.32 (0.08-1.3)0.11 (-1.61)6-9 years11110-14 years1.5 (0.65- 3.4)0.34 (0.95)1.02 (0.50-2.1)0.94 (0.07)1.9 (0.58- 6.4)0.28 (1.08)Infection intensity*S. mansoni*0.83 (0.55-1.2)0.36 (-0.90)0.99 (0.69-1.4)0.96 (-0.04)2.0 (1.1-3.9)0.03 (2.17)*S. haematobium*2.4 (1.3- 4.5)0.007 (2.68)6.7 (3.29-13.60)\<0.001 (5.26)0.55 (0.21- 1.4)0.22 (-1.21)

4. Discussion {#sec0080}
=============

A regular morbidity data collection has not been conducted countrywide in Mali for long term impact monitoring of MDA since our 2005 survey due to lack of resources. Records from the National Schistosomiasis Control Program and results from the literature review show that since our February 2005 survey, only very limited morbidity data (anaemia, haematuria and organomely) were collected in three villages from the Ségou district. These were located just outside the Office du Niger. This occurred in 2007--2009 as part of a larger multidisciplinary study ([@bib0280]). The second study was by [@bib0245] on urinary tract pathology, nutritional status and anaemia in Koulikoro and Selingue, in 6 villages, far away from the Office du Niger. From the 2005 research we have quite a unique dataset on anaemia, haematuria and bladder pathology one year from the start of the MDA program (near-baseline data) concerning schistosomiasis in children in the Office du Niger, Macina district, where there is an ongoing MDA with PZQ in Mali. This is key data to compare with future surveys to enable the effectiveness of the ongoing MDA program to be evaluated.

Key findings of this micro-epidemiological study were the strikingly high prevalence of pathologies that included anaemia in 91% of surveyed children and that 80% of the children examined were co-infected with *S. mansoni* and *S. haematobium.* The morbidities that were identified were likely attributable to schistosomiasis, given the hyper-endemicity of this parasite in our children, although a component of the anaemia observed may be due to other factors. Our findings concur with other similar findings ([@bib0025]; [@bib0035]; [@bib0155]; [@bib0165]).

There is evidence that the length of exposure to schistosomiasis, and host and parasite genetics may impact a child's response to PZQ as well as the child's host response ability to modulate reactions to the parasite ([@bib0335]). The likely cause of high intensity of infections and associated morbidity in our village could have been a result of an interruption to the mollusciciding programs and inappropriate MDA coverage prior to 2004. Co-infections of schistosomes only or in association with other parasites (e.g. STH and *P. falciparum*) in children elevates risk of morbidity ([@bib0085]; [@bib0195]; [@bib0230]). Higher *S. haematobium*- and *S. mansoni*-associated morbidity in co-infections relative to single *Schistosoma* infections have been reported in Mali ([@bib0150]) and Kenya ([@bib0105]).

4.1. Anaemia {#sec0085}
------------

The results of our study show that anaemia was almost universal. The prevalence of anaemia in our study, 91%, was higher than the average 40% for Mali in school-age children, suggesting anaemia is a serious public health problem in the region. A recent study in three villages located just outside the ON support this ([@bib0280]). In the region of the Office du Niger the rate of anaemia mirrors Mali with 84% in preschool-age children and 58% in women of reproductive age ([@bib0270]).

Anaemia in our children was significantly associated with the intensity of *S. mansoni* infection, concurring with a report from Tanzania ([@bib0005]) while in contrast to Uganda ([@bib0310]). We believe our findings may indicate a unique relationship between *S. mansoni* infection and anaemia possibly in part anaemia of inflammation, the result of an inflammatory mechanism causing a high level of serum ferritin (\>100 ng/mL) due to iron sequestration (storage) from iron-dependent host tissues ([@bib0030]; [@bib0090]).

The anaemia detected in children with *S. mansoni* infection may be related to insufficient iron intake, haemoglobinopathies, micronutrient deficiencies (vitamin A, B12, folate and riboflavin) ([@bib0195]; [@bib0225]; [@bib0255]; [@bib0300]) and social factors ([@bib0255]). Other risk factors include parasitic infections such as *Plasmodium falciparum* malaria ([@bib0220]; [@bib0225]; [@bib0260]), *H. nana* ([@bib0205]), and hookworm infection ([@bib0100]; [@bib0155], [@bib0160]; [@bib0185]; [@bib0210]; [@bib0230]; [@bib0285]; [@bib0290]). We found the prevalence of *Hymenolepsis nana* to be very low in our study area and we could not detect STH in our 2007 investigation (unpublished).

Contrary to other reports from Ségou district ([@bib0280]), Selengue and Koulikouro regions ([@bib0245]; [@bib0280]) we did not find an association between *S. haematobium* infection and anaemia ([Table 3](#tbl0015){ref-type="table"} and S2) and this may be due to small sample size.

We found anaemia was hyper-endemic in both females, 86%, and males, 96%, while other reports found anaemia to be more common in male children ([@bib0180]; [@bib0200]; [@bib0280]). Our finding that anaemia was more common in 10--14 year olds than younger children, 6--9 years of age, concurred with others ([@bib0010]; [@bib0110]; [@bib0315]) while others have reported anaemia actually improved in teenage years ([@bib0180]; [@bib0340]). Of note, a recent study in Ségou district shows that anemia related to *S. haematobium* infection was most pronounced in the 2--5 year olds males across ages and genders ([@bib0280]), suggesting anaemia is a serious public health problem in under 5 years old children. We believe our finding reflects a greater exposure to contaminated water in our older children while they assist their families fishing and farm irrigation as well as during leisure time ([@bib0020]; [@bib0250]). Control of this exposure requires a culture change where children in the Kokry-Bozo region are kept away from working and playing in the water.

Multiple causes of anaemia present a challenge when designing effective intervention programs. Regardless of cause, iron supplementation in Kokry-Bozo needs to be considered for distribution as a therapeutic and preventive strategy. However, appropriate PZQ dosing and duration would eliminate an important risk factor, *S. mansoni*, for anaemia. With potential multiple risk factors for anaemia in the Kokry-Bozo region simultaneous control strategies for malaria ([@bib0260]) and addressing poverty ([@bib0080]) are needed.

4.2. Bladder pathology and haematuria {#sec0090}
-------------------------------------

Our findings suggest that bladder pathology and micro-haematuria were not infrequently diagnosed in children with *Schistosoma* infection from Kokry-Bozo village. According to a 2007--2009 study in three villages in Ségou district (located just outside the ON), 61% of individuals of both sexes across 2--40 years of age have micro-haematuria related to *S. haematobium* infection ([@bib0280]). This is in line with our finding, suggesting that micro-haematuria continues to be a serious public health issue in the Ségou region. A 2010 study conducted in two different areas (Koulikoro district and Selingué dam) confirms our observation of high level of urinary pathology in Mali ([@bib0245]).

Currently the prevalence of bladder pathology and haematuria in children not infected or infected with only one species of schistosomiasis was not estimated the small sample size. But a simple history of blood in children's urine could provide a good indication of *S. haematobium* ([@bib0115]; [@bib0125]; [@bib0130]; [@bib0175]; [@bib0325]). The exact mechanisms behind the micro-haematuria and bladder pathology in children infected with only *S. mansoni* may be the result of the low sensitivity of the urine filtration method failing to detect a mild urinary *S haematobium* infection ([@bib0145]), bacteria urinary tract infection, glomerulonephritis, urinary tract tumour and sickle cell anaemia ([@bib0065]; [@bib0190]). Our findings of co-infections might suggest inter-species pairing has occurred where *S. haematobium* males paired with female *S. mansoni* that deviated the eggs to the urinary tract ([@bib0055]; [@bib0150]). But even if this uncommon pairing had occurred it does not explain the prevalence of haematuria.

5. Limitations and strengths {#sec0095}
============================

The interpretation of the morbidity results is limited by a lack of adjustment for potential confounding factors that are not easy to measure or statistically control such as: degree and duration of exposure to schistosome pathogens, other parasitic diseases, viral infections, poor nutrition or micronutrient deficiencies, inherited haemoglobinopathies and thalassemia. In particular, poor sanitation, high levels of water contact and poor resources for decontamination of water observed during field trips could be major confounders. Research into improved statistical and epidemiological adjustment for these confounders in small village studies would be beneficial. Notwithstanding this methodological shortfall, our use of ultrasonography demonstrated a significant burden of abnormal bladder pathology in our sample of co-infected children. This is an important avenue for further research.

6. Conclusion {#sec0100}
=============

Aetiological factors including the degree that schistosomiasis contributes to anaemia, bladder pathology and haematuria may be difficult to determine, especially at the level of village surveys. Our results indicate that there was association between level of morbidity and infection intensity. Our study has provided a micro-epidemiological insight into morbidities in a village where the prevalence of schistosomiasis has remained hyper-endemic following one round of treatment. This treatment was part of the SCI MDA program and has continued from 2005 until now. Morbidities we measured were so commonplace in the school children that control strategies should include concurrent improvement in water and sanitation as well mollusciding, micronutrients supplementations and malaria control. Due to limited morbidity data between 2006 and 2019, there is a need for a comparable but more extensive study. It is necessary to identify any changes in morbidity and to indicate current requirements for the control programme in Mali.
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[^1]: P (χ^2^): *P*-value and χ^2^ from Pearson chi-square test of normal status versus all other anaemic status.
